TL;DR: Goodfire raised $150M Series B at $1.25B valuation to build AI interpretability tools. They’ve reduced hallucinations by 50% and discovered Alzheimer’s biomarkers by understanding what’s happening inside AI models. Customers include Arc Institute, Mayo Clinic, and Microsoft.

The Numbers

MetricValue
Series B$150 million
Valuation$1.25 billion
Lead InvestorB Capital
Hallucination Reduction50%
Key CustomersArc Institute, Mayo Clinic, Microsoft

Why This Matters

Every frontier AI model is a black box. Foundation models are now:

  • Writing significant amounts of production code
  • Running loose on the internet
  • Integrated into military systems

Yet we don’t understand how they make decisions. Goodfire’s thesis: we need to “open the black box” to build models that are powerful but also steerable and safe.

Real Results

Goodfire isn’t just doing research. They’ve delivered concrete outcomes:

  1. Reduced hallucinations by 50% using interpretability-informed training
  2. Identified novel Alzheimer’s biomarkers by reverse-engineering a biological model
  3. Built production monitoring tools for enterprise customers

The Technology

Their “model design environment” provides:

  • Interpretability-based primitives for insights
  • Tools to improve model behavior
  • Production monitoring capabilities
  • Shared collaboration with customers

Customer Quote

“Interpretability, for us, is the toolset for a new domain of science: a way to form hypotheses, run experiments, and ultimately design intelligence rather than stumbling into it.”

— Eric Ho, CEO of Goodfire

The Investors

  • B Capital (lead)
  • Juniper Ventures
  • DFJ Growth
  • Salesforce Ventures
  • Menlo Ventures
  • Lightspeed Venture Partners
  • South Park Commons
  • Wing Venture Capital
  • Eric Schmidt

FAQ

What does Goodfire do? Goodfire builds interpretability tools that let you understand and edit what’s happening inside AI models.

How much is Goodfire worth? $1.25 billion after the Series B.

What results has Goodfire achieved? They reduced hallucinations by 50% and identified novel Alzheimer’s biomarkers.

Who uses Goodfire? Arc Institute, Mayo Clinic, and Microsoft are customers.

Who invested in Goodfire? B Capital led the round, with participation from Salesforce Ventures, Lightspeed, Menlo Ventures, and Eric Schmidt.


Last verified: March 1, 2026

Sources: